Manufacturing

Qualcomm Technologies, Inc., announced the winners of the Qualcomm Innovation Fellowship (QIF) Europe program, now in its 15th year.

Keysight Technologies, Inc. (NYSE: KEYS), has been recognized by Forbes as one of the Best Employers for Diversity in 2024. Keysight was listed for the second consecutive year, earning the 8th ranking out of 500 U.S.-based companies.

Wesco is dedicated to improving our environmental management through setting, achieving, and striving toward new goals. Strong environmental management is an advantage for our business as we implement new practices to reduce our impacts, benefiting our customers and communities.

Buildings are today responsible for 37% of emissions when considering both direct and indirect emissions (United Nations Environment Programme, 2022), and should be at the core of decarbonization policies worldwide.

Illumina ranks 5th overall and is the top-ranking company in the U.S. and the biotechnology industry in TIME’s ‘World's Most Sustainable Companies 2024’ list. The list ranks the top 500 companies out of more than 3,000 reviewed.

Getting a restful night’s sleep is important to our overall health and well-being. With Naia™ Renew, you can get there with three key benefits that ensure you’ll wake up refreshed, restored and at ease: comfort, long-lasting quality, and sustainability.

Shout out to our amazing associates at the Old Course Hotel, Golf Resort & Spa in St Andrews, Scotland, for achieving a Green Tourism Gold Award!

In honor of National Forest Week, International Paper (IP) and longtime partner National Fish and Wildlife Foundation (NFWF) celebrate the collaboration between public and private partners that is essential to supporting robust forests and wildlife throughout the Southeast.

In honor of Pride Month this June, HARMAN celebrated with a vibrant series of events, sponsored by our Pride Employee Resource Group (ERG), in support of the LGBTQIA+ community.

Jazz Pharmaceuticals remains committed to its core mission to develop life-changing medicines for people with serious diseases, often with limited therapeutic options.